Association of routine platelet indices with angina pectoris and myocardial infarction: a retrospective observational study with multivariable adjustment and propensity score matching

The human heart relies on a steady flow of blood through a network of arteries, but this system is vulnerable to a slow, silent buildup of fatty deposits known as plaque. When these deposits harden or rupture, they can trigger a sudden blockage, leading to a heart attack or the chest pain known as angina. For decades, doctors have understood that tiny cell fragments called platelets play a central role in this crisis. When a vessel is damaged, platelets rush to the scene, sticking together to form a clot. Sometimes, this natural healing response goes into overdrive, creating a dangerous blockage. Because platelets are so involved in these events, scientists have long wondered if the physical characteristics of these cells could serve as a warning sign. Specifically, they have looked at how big the platelets are, how much they vary in size, and how much total space they occupy in the blood. These measurements are already part of a standard blood test that almost anyone can get, raising the question of whether a simple glance at these numbers could reveal the hidden stress of heart disease.

A team of researchers at Pingtung Christian Hospital in Taiwan decided to investigate this question by looking at real-world data from nearly 840 adults. They gathered information from three distinct groups: people who came in for routine health checkups with no known heart issues, patients who were diagnosed with stable chest pain, and patients who had suffered a heart attack. The goal was to see if the size and shape of their platelets differed in a way that clearly separated the healthy group from those with heart disease. The researchers focused on three specific measurements that are automatically generated by modern lab machines: the average size of the platelets, the variation in their sizes, and the total volume they take up in the blood sample. They wanted to know if these numbers were simply higher or lower in sick patients, or if the differences were actually caused by other factors like age, sex, blood sugar levels, or kidney function.

The initial look at the data showed clear differences between the groups. People who had suffered a heart attack or had chest pain tended to have slightly larger platelets on average, and their platelets varied more in size compared to the healthy group. The total volume of platelets in their blood was also slightly lower. However, the researchers knew that these groups were not identical in other ways. The patients with heart disease were, on average, older and more likely to be male. They also had higher levels of blood sugar and lower kidney function, all of which are known to affect how blood cells behave. To find the true signal of heart disease, the team used statistical tools to adjust for these differences, effectively asking what the platelet numbers would look like if everyone in the study were the same age and sex, and had similar metabolic health.

When the researchers adjusted for age and sex, the differences in platelet size remained, but they became smaller. The group with heart attacks still had larger platelets than the healthy group, but the gap narrowed. The most telling result came when the researchers added adjustments for blood sugar and kidney function. At this point, the variation in platelet sizes lost its statistical significance, suggesting that the earlier differences were largely driven by these metabolic and kidney factors rather than the heart disease itself. However, two specific measurements held their ground. The average size of the platelets remained slightly larger in the heart attack group, and the total volume they occupied remained slightly lower, even after accounting for age, sex, blood sugar, and kidney health. These differences were small, measured in tiny fractions of a unit, but they were consistent enough to be noticed across the large group of patients.

The study also examined whether the type of chest pain mattered, comparing patients with stable, predictable pain against those with unstable, unpredictable pain. The researchers found no clear difference in platelet measurements between these two subgroups, suggesting that these routine blood tests cannot distinguish between the severity of chest pain on their own. Furthermore, they discovered that one of the measurements, which counts the proportion of large platelets, was so closely linked to the average size measurement that it provided almost no new information. It was like measuring the same thing twice in slightly different ways. The researchers concluded that while these platelet numbers do change in people with heart disease, the changes are modest and heavily influenced by the body's overall metabolic and kidney health.

Ultimately, the findings suggest that these routine platelet indices should not be used as standalone diagnostic tools to identify heart disease. They are not specific enough to say with certainty that a person has a blocked artery based on a single blood test. Instead, the study indicates that these numbers are better viewed as part of a larger picture. They reflect the complex environment of the body, including how the kidneys and metabolism are functioning, rather than acting as a direct fingerprint of a heart attack. For doctors, this means that while these numbers can add a small piece of context to a patient's overall health profile, they cannot replace the established methods of diagnosis, such as electrocardiograms and specific heart biomarkers. The research reinforces the idea that the body's blood cells are sensitive to many different internal conditions, and understanding heart disease requires looking at the whole system, not just a single, small measurement.